Functional Neuromodulation
Medical Equipment - Minneapolis, MN, US
Functional Neuromodulation Employees
Functional Neuromodulation Senior Management
Functional Neuromodulation Details
Functional Neuromodulation Ltd., in partnership with Boston Scientific, is investigating the use of deep brain stimulation of the fornix (DBS-f) to drive neural activity and modulate the brain's memory circuit. The company completed a Phase II multi-center clinical trial of DBS-f in 42 patients with mild probable Alzheimer's in 2016.Functional Neuromodulation is dedicated to advancing the application of deep brain stimulation (DBS) therapies to help improve the lives of people with mild Alzheimer's disease. Investors include Boston Scientific, Genesys Capital Partners, and MS Pace. CAUTION — Investigational device. Limited by Federal law to investigational use
Functional Neuromodulation Technologies
Load Balancers
Apache
Analytics and Tracking
Google Analytics
Online Video Platforms
YouTube